iyotee Secures $9.35 Million In Series A Funding and Launches KnowledgeNet.ai

New AI-Driven Network Collaboration App Revolutionizes How Organizations Use Their Intellectual Capital

By James Alvord | February 11, 2022

FREDERICK MD, February 09, 2022 – KnowledgeNet.ai, a leader in knowledge intelligence, announced today that it has raised a $9.35M Series A investment round through syndicate investors. KnowledgeNet.ai goes beyond relationship intelligence to combine relationship intelligence, knowledge... Read more


FITCI Receives 2022 Grant from Rural Maryland Council

The Rural Maryland Prosperity Investment Fund Grant Will Help Build an Agricultural Technology Lab

By FITCI | October 20, 2021

(Frederick, MD) Frederick Innovative Technology Center, Inc (FITCI) was awarded Rural Maryland Council’s Rural Maryland Prosperity Investment Fund Grant for 2022 for the Ag-Tech Lab project, part of FITCI’s new Innovation Center. The funding, along with help from collaborators and partners like... Read more


FITCI earns Rural Maryland Council Outstanding Rural Economic Development Award

For Outstanding Leadership and Public Service in Advocating Policy Solutions to Greatly Benefit Rural Communities.

By April Bartel | December 07, 2021

The Frederick Innovative Technology Center, Inc. (FITCI) was recently honored for Outstanding Rural Economic Development by the Rural Maryland Council (RMC). The award was presented as part of the 2021 Rural Summit held in Annapolis on December 1 and 2. The event’s theme was Redefining... Read more


FITCI helps fellow nonprofits by “Giving BACK”

Board and staff volunteer, sharing the spirit of gratitude and generosity

By April Bartel | December 07, 2021

If November sparks gratitude and December is devoted to giving, now is a perfect time to acknowledge the good while renewing the spirit of fellowship and community. In response, team members at the Frederick Innovative Technology Center, Inc. (FITCI), a nonprofit dedicated to facilitating... Read more


Mesa Green Pharma LLC. Receives Positive Feedback from FDA’s Center for...

Pilot Study Provides Positive Results for K9MGP Treatment Active Canine Seizures

By Michael Mesa | September 27, 2021

FREDERICK, Md. September 21,2021— Mr. Michael Mesa, CEO of Mesa Green Pharma (MGP) stated that “company representatives met with FDA’s Center for Veterinary Medicine (CVM) on September 9, 2021, to discuss the company’s development program for K9MGP.” MGP is developing K9MGP as a treatment... Read more


Nanobiofab Earns $1.1M Defense Health Agency SBIR Grant for AI-powered platform

Novel nanomaterials measure pressure and volatile chemical compounds

By April Bartel | September 19, 2021

Frederick, Maryland – Tao Treasures LLC DBA Nanobiofab, a minority woman-owned nanotech startup in the Frederick Innovative Technology Center, Inc. (FITCI), is helping medical mannequins tell doctors where it hurts. The company, which creates revolutionary million-scale nanomaterial used in ... Read more


Dr. Ruoting Yang in Molecular Psychiatry on biotypes for PTSD

NanoBioFab co-founder garners industry attention

By | July 01, 2021

Geneva Scientist Dr. Ruoting Yang first-authored a manuscript published in Molecular Psychiatry on biotypes for post-traumatic stress disorder (PTSD), the first of their kind of any psychological disorder. Dr. Yang is a Computational Biologist, specializing in artificial intelligence,... Read more


THERADAPTIVE: shaping the future of regenerative medicine at military treatment...

Advanced theraputic can mean the difference between amputation and limb preservation

By The Geneva Foundation | June 30, 2021

The Geneva Foundation released a case study highlighting their work with FITCI member, Theradaptive. Theradaptive is shaping the future of regenerative medicine with a new platform to deliver therapeutics that promote targeted native tissue repair. Their lead therapeutic, AMP2, is applied... Read more


Veralox Therapeutics Appoints Michael Hanna as Chief Medical Officer

By Veralox Therapeutics | June 23, 2021

FREDERICK, MD – June 23, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Michael S. Hanna, MD, FACC, as chief... Read more


Old Line Capital Invests in CarrTech

Columbia, Maryland, June 10, 2021

By April Bartel, FITCI | June 18, 2021

Old Line Capital Partners announced today that they have made a significant investment in CarrTech LLC, to extend product development, sales, and marketing of CarrTech’s innovative filter needle. “CarrTech’s FROG device (Filter Removal of Glass) saves lives, prevents injury, and saves... Read more


Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And...

By Veralox Therapeutics | June 16, 2021

FREDERICK, Md., June 16, 2021 -- Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the closing of a $16.6 million Series A financing. The round... Read more


Betamore & FITCI Expand Founder City

Pitch Competition Deadline Extended & Final Celebration Moved to Fall 2021

By April Bartel, FITCI | May 20, 2021

Baltimore, MD and Frederick, MD: Founder City, an impactful, hybrid conference-event created in collaboration by Betamore and Frederick Innovative Technology Center, Inc. (FITCI) has expanded its weekly programming and is extending its pitch competition deadline, thanks to strong support from... Read more


Coinbase adds Tellor, a Frederick-based cryptocurrency startup

By April Bartel, FITCI | May 19, 2021

Frederick MD – There’s been a lot of buzz about cryptocurrency, Bitcoin, and NFTs (non-fungible tokens) these days, and even small, mainstream investors are taking note, but one Maryland startup is playing the long game. Frederick-based Tellor started in March 2019, founded by Nicholas Fett,... Read more


BioSolution Designs Raises Seed Round

BioSolution Designs closes initial Seed Round of funding to accelerate its ongoing product invention activities.

By BIOSOLUTION DESIGNS | May 05, 2021

Frederick, MD., May 5, 2021 -- BioSolution Designs, LLC, announces that initial Seed Round goals are met and full operation begins as of May 1. BSD Founder and President, Dr. Thomas Reed, will direct use of the funding to accelerate existing collaborative initiatives developed over the past year.... Read more


Minnodi Empowers Women

By April Bartel, FITCI | May 04, 2021

Frederick, MD: Santhanalakshmi Shanmugam appreciates the unique challenges women face when entering the workforce, especially in the demanding fields of science and technology. She founded Minnodi, LLC, a Maryland-based Women Owned Business focusing on IT/Pharma consulting and staffing agency... Read more


Betamore & FITCI Announce Founder City

By Betamore & FITCI | April 01, 2021

Baltimore, MD and Frederick, MD: Betamore and Frederick Innovative Technology Center, Inc. (FITCI) have announced their collaboration on a new, more impactful, hybrid conference event, Founder City. Founder City brings together into one event some of the most essential pillars of the startup... Read more


Leading diagnostics laboratory in the Caribbean selects NextGenPCR for...

Clinical implementation of ultra-fast molecular testing improves time to result and laboratory throughput

By Brian McNally, CEO of VelocidyBio | March 31, 2021

Goes, Netherlands, March 31, 2021 -- Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that Aruba’s Laboratorio di Servicio (LdS) has validated and implemented NextGenPCR for SARS-CoV-2 testing. With a single NextGenPCR system capable of producing over 1,000 results... Read more


M Power Education Records Explosive Growth During the COVID-19 Pandemic

By Ivana Shuck | March 17, 2021

Frederick, MD (March 17, 2021) – M Power Education, a Frederick-based e-learning and career training company, has experienced an explosive growth in the past year, despite the global pandemic. The company grew from three to fifteen employees and expanded their client base as well as student... Read more


Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005

By Jeff Strovel, Veralox CEO | January 26, 2021

FREDERICK, Md – January 26, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has... Read more


Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat...

By Jeff Strovel, Veralox CEO | January 12, 2021

FREDERICK, Md – January 12, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted an Investigational New Drug (IND)... Read more